Suppr超能文献

使用经过验证的抗菌乳房口袋灌洗来提高美容乳房植入手术的患者效果:20 年随访。

Enhancing Patient Outcomes in Aesthetic Breast Implant Procedures Using Proven Antimicrobial Breast Pocket Irrigations: A 20-Year Follow-up.

出版信息

Aesthet Surg J. 2023 Jan 9;43(1):66-73. doi: 10.1093/asj/sjac238.

Abstract

BACKGROUND

Capsular contracture (CC) remains the most common complication of implant-based aesthetic and reconstructive breast surgery. With subclinical infection proven to be the primary etiology, antimicrobial breast pocket irrigation has been recommended as the key step to reduce CC but has not been universally adopted.

OBJECTIVES

The purpose of this study was to review the rates of CC observed when applying proven antimicrobial breast pocket irrigations.

METHODS

Data from patients undergoing cosmetic breast augmentation were recorded prospectively from 1997 to 2017. The irrigation was performed with either a Betadine-containing (50% Betadine or "Betadine triple") or a non-Betadine triple antibiotic regimen. The database was assessed to determine the type of implant used, the incidence of CC, and possible contributing factors. The degree of CC was recorded according to the Baker classification.

RESULTS

A 20-year prospective data collection yielded 2088 patients with 4176 implants; of these patients, 826 had textured implants and 1262 had smooth implants. The incidence of Grade III/IV CC was found to be 0.57% in all patients undergoing primary breast augmentation (1.21% in textured implants and 0.16% in smooth implants).

CONCLUSIONS

This study constitutes the largest and longest review of CC in a controlled, single-surgeon setting. The incidence of CC is low and reinforces the efficacy/utility of antimicrobial breast pocket irrigation. Both the Betadine and non-Betadine antibiotic regimens were found to be effective, with the Betadine regimen being preferred. Universal adoption of Betadine-containing antimicrobial breast pocket irrigation is recommended to reduce CC and other device-associated infections.

摘要

背景

包膜挛缩(Capsular contracture,CC)仍然是假体乳房美容和重建手术最常见的并发症。亚临床感染已被证明是其主要病因,因此推荐使用抗菌乳房口袋冲洗作为降低 CC 发生率的关键步骤,但尚未被普遍采用。

目的

本研究旨在回顾应用已证实的抗菌乳房口袋冲洗液时观察到的 CC 发生率。

方法

从 1997 年至 2017 年,前瞻性地记录了接受美容乳房隆乳术患者的数据。冲洗液采用含聚维酮碘(50%聚维酮碘或“聚维酮碘三联”)或非聚维酮碘三联抗生素方案。评估数据库以确定使用的植入物类型、CC 的发生率以及可能的促成因素。CC 的严重程度根据 Baker 分类进行记录。

结果

20 年的前瞻性数据收集共纳入 2088 例患者和 4176 个植入物;其中 826 例患者使用了纹理植入物,1262 例患者使用了光滑植入物。原发性乳房隆乳术中,所有患者的 CC III/IV 级发生率为 0.57%(纹理植入物为 1.21%,光滑植入物为 0.16%)。

结论

本研究是在控制、单外科医生环境下对 CC 进行的最大和最长的回顾。CC 的发生率较低,这进一步证实了抗菌乳房口袋冲洗的有效性/实用性。聚维酮碘和非聚维酮碘抗生素方案均有效,聚维酮碘方案更受欢迎。建议普遍采用含聚维酮碘的抗菌乳房口袋冲洗液,以降低 CC 和其他与器械相关的感染。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验